Document Server@UHasselt >
Research >
Research publications >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/24961

Title: Grip Strength in Women Being Treated for Breast Cancer and Receiving Adjuvant Endocrine Therapy: Systematic Review
Authors: Van der Weijden-Van Doornik, E. M.
Slot, Dagmar E.
Burtin, Chris
van der Weijden, G. A.
Issue Date: 2017
Citation: PHYSICAL THERAPY, 97(9), p. 904-914
Abstract: Background. Adjuvant endocrine therapy in breast cancer has increased survival rates; however, it is not without musculoskeletal side effects. Purpose. The purpose of this review was to systematically and critically appraise the available scientific evidence concerning the effect of adjuvant endocrine treatment on grip strength in women being treated for breast cancer. Data sources and study selection. The National Library of Medicine (MEDLINE-PubMed),Cochrane Central Register of Controlled Trials (CENTRAL), Excerpta Medical Database by Elsevier (EMBASE), Cumulative Index to Nursing and Allied Health Literature (CINAHL), and Physiotherapy Evidence Database (PEDro) were searched from inception to February 2017 for appropriate papers that could answer the focused question. The searches were independently screened by 2 reviewers. The data from 7 papers that met the eligibility criteria were processed for further analysis. Data extraction and synthesis. The collective data and the statistical analysis of all included studies were summarized and presented in a descriptive manner. If not provided, based on data from the individual included studies, a mean percent change in grip strength was calculated. The included studies evaluating aromatase inhibitors had inconclusive outcomes, and studies with a follow-up of 6 or 12 months showed a percent reduction in grip strength varying from 0.1% to 9.7%. None of the included studies showed a significant decrease in grip strength in tamoxifen users, with a percent reduction in grip strength varying from 1.4% to 2.2%. Limitations. The 7 studies included cohort studies lacking a control group. Conclusions. There is inconclusive evidence for a small decrease in grip strength in women treated for breast cancer who are also receiving aromatase inhibitors. In those that use tamoxifen, grip strength did not change significantly.
Notes: [Van der Weijden-Van Doornik, E. M.] Fysiotherapeuten Maatschap Woerden, Woerden, Netherlands. [Slot, Dagmar E.; van der Weijden, G. A.] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Periodontol, Amsterdam, Netherlands. [Slot, Dagmar E.; van der Weijden, G. A.] Vrije Univ Amsterdam, Amsterdam, Netherlands. [Burtin, Chris] Hasselt Univ, Fac Med & Life Sci, Biomed Res Inst, Rehabil Res Ctr, Diepenbeek, Belgium.
URI: http://hdl.handle.net/1942/24961
DOI: 10.1093/ptj/pzx069
ISI #: 000408900600006
ISSN: 0031-9023
Category: A1
Type: Journal Contribution
Validation: ecoom, 2018
Appears in Collections: Research publications

Files in This Item:

Description SizeFormat
Published version1.02 MBAdobe PDF

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.